A New Salvage Regimen for Aggressive Lymphomas Based on Gemcitabine, Rituximab, and Oxaliplatin Followed by Lenalidomide (GROC-Rev)
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia December 2019 19(12):776-783 - Subject
- Language
- ISSN
- 2152-2650